Insider Transactions in Q4 2024 at Immunome Inc. (IMNM)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 22
2024
|
Clay B Siegall President and CEO |
BUY
Open market or private purchase
|
Direct |
33,943
+6.13%
|
$305,487
$9.78 P/Share
|
|
Nov 21
2024
|
Clay B Siegall President and CEO |
BUY
Open market or private purchase
|
Direct |
66,057
+11.97%
|
$594,513
$9.54 P/Share
|
|
Nov 21
2024
|
Robert Lechleider Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
15,805
+50.0%
|
$142,245
$9.48 P/Share
|
|
Nov 21
2024
|
Philip Tsai Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
21,000
+50.0%
|
$189,000
$9.43 P/Share
|